Clinical Trial Update: Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the safety and efficacy of OD-07656 with subsequent vedolizumab therapy for moderately to severely active ulcerative colitis; recruitmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• OD-07656
• Vedolizumab (vedolizumab)

Snippet

Sponsor: Odyssey Therapeutics | Conditions: Ulcerative Colitis (UC), UC - Ulcerative Colitis | Phase 2 | Status: RECRUITING